OXYTOCIN: EFFECTS AND RISKS IN PREGNANT WOMEN
DOI:
https://doi.org/10.11603/24116-4944.2025.2.15796Keywords:
oxytocin, pregnancy, puerpera, labor, fetus, newbornAbstract
The aim of the study – to analyze the literature data on the properties of oxytocin, a drug widely used in obstetric and gynecological practice. Its role as a neurotransmitter has been demonstrated, exerting a significant influence on almost all organs and systems, as well as on social, behavioral, and mental responses of individuals. In obstetric practice, oxytocin is prescribed according to established protocols; however, many details contradict the information provided in the drug instructions. Both clinical practice and literature data indicate the necessity of further research regarding minimal effective doses, routes of administration, and its effects on the mother and fetus.
Conclusions. The need to introduce the issue of finding optimal oxytocin regimens that will minimize the risks of hyperstimulation while ensuring the effectiveness of therapy.
References
1. Dale, H.H. (1909). The action of extracts of the pituitary body. Biochemical Journal, 4(9), 427–447. https://doi.org/10.1042/bj0040427
2. Grigor’eva, M.E., & Golubeva, M.G. (2010). Oxytocin: Structure, synthesis, receptors, and basic effects. Neurochemical Journal, 4(2), 75–83.
3. Du Vigneaud, V., Ressler, C., & Trippett, S. (1953). The sequence of amino acids in oxytocin, with a proposal for the structure of oxytocin. Journal of Biological Chemistry, 205(2), 949–957.
4. Arrowsmith, S., & Wray, S. (2014). Oxytocin: Its mechanism of action and receptor signalling in the myometrium. Journal of Neuroendocrinology, 26(6), 356–369. https://doi.org/10.1111/jne.12154
5. Chevaleyre, V., Dayanithi, G., Moos, F., & Desarmenien, M. (2000). Developmental regulation of a local positive autocontrol of supraoptic neurons. Journal of Neuroscience, 20(15), 5813–5819.
6. Ludwig, M. (1998). Dendritic release of vasopressin and oxytocin. Journal of Neuroendocrinology, 10, 881–895. https://doi.org/10.1046/j.1365-2826.1998.00375.x
7. Vrachnis, N., Malamas, F.M., Sifakis, S., Deligeoroglou, E., & Iliodromiti, Z. (2011). The oxytocin–oxytocin receptor system and its antagonists as tocolytic agents. International Journal of Endocrinology, 2011, Article ID 350546. https://doi.org/10.1155/2011/350546
8. Norbert, C.J., & Heck, A.J.R. (2010). The effect of oxytocin and an oxytocin antagonist on the human myometrial proteome. Reproductive Sciences, 17, 40–46. https://doi.org/10.1177/1933719109348220
9. Plevrakis, I., Calmagirand, C., & Pontonnier, G. (1990). Oxytocin biosynthesis in serum-free cultures of human granulosa cells. Journal of Endocrinology, 124, 5–11. https://doi.org/10.1677/joe.0.1240005
10. Saller, S.L., Kunz, G.A., & Dissen, R.S. (2010). Oxytocin receptors in the primate ovary: Molecular identity and link to apoptosis in human granulosa cells. Human Reproduction, 25(4), 969–976. https://doi.org/10.1093/humrep/deq012
11. Zeeman, G.G., Khan-Dawood, F.S., & Dawood, M.Y. (1997). Oxytocin and its receptor in pregnancy and parturition: Current concepts and clinical implications. Obstetrics & Gynecology, 89(5 Pt 2), 873–883. https://doi.org/10.1016/S0029-7844(97)00056-2
12. Rekawiecki, R., Nowocin, A., & Kotwica, J. (2010). Relationship between concentrations of progesterone, oxytocin, noradrenaline, gene expression and protein level for their receptors in corpus luteum during estrous cycle in the cow. Prostaglandins & Other Lipid Mediators, 92, 13–18. https://doi.org/10.1016/j.prostaglandins.2010.04.003
13. Gordon, I., Vander Wyk, B.C., Bennett, R.H., et al. (2013). Oxytocin enhances brain function in children with autism. Proceedings of the National Academy of Sciences of the United States of America, 110(52), 20953–20958. https://doi.org/10.1073/pnas.1312857110
14. Watanabe, T., Abe, O., Kuwabara, H., et al. (2014). Mitigation of sociocommunicational deficits of autism through oxytocin-induced recovery of medial prefrontal activity: A randomized trial. JAMA Psychiatry, 71(2), 166–175. https://doi.org/10.1001/jamapsychiatry.2013.3181
15. Smith, J., et al. (2021). The role of oxytocin in the inflammatory response in endometriosis. Journal of Reproductive Immunology, 143, 103245. https://doi.org/10.1016/j.jri.2020.103245
16. Jones, L., et al. (2022). Oxytocin promotes angiogenesis in endometrial tissue through VEGF activation. Journal of Endocrinology, 234(2), 125–136. https://doi.org/10.1530/JOE-21-0307
17. Watson, K., et al. (2023). Matrix metalloproteinases in endometriosis: Regulation by oxytocin. Molecular Endocrinology, 37(3), 567–578. https://doi.org/10.1210/me.2023-00045
18. Oladapo, O.T., Okusanya, B.O., & Abalos, E. (2018). Intramuscular versus intravenous prophylactic oxytocin for the third stage of labour. Cochrane Database of Systematic Reviews, 9, CD009332. https://doi.org/10.1002/14651858.CD009332.pub3
19. Chaika, G.V., & Kucherenko, O.M. (2018). Method for determining the possibility of pubertal uterine bleeding in girls depending on body structure, uterine and ovarian sonographic parameters, and hormonal background. Vinnytsia National Medical University Repository. Retrieved November 24, 2025, from https://dspace.vnmu.edu.ua/handle/123456789/1306.
20. Chibbar, R., Miller, F.D., & Mitchell, B.F. (1993). Synthesis of oxytocin in amnion, chorion, and decidua may influence the timing of human parturition. Journal of Clinical Investigation, 91(1), 185–192. https://doi.org/10.1172/JCI116169.
21. Shojo, H., & Kaneko, Y. (2000). Characterization and expression of oxytocin and the oxytocin receptor. Molecular Genetics and Metabolism, 71(4), 552–558. https://doi.org/10.1006/mgme.2000.3094.
22. Blanks, A.M., Vatish, M., Allen, M.J., et al. (2003). Paracrine oxytocin and estradiol demonstrate a spatial increase in human intrauterine tissues with labor. Journal of Clinical Endocrinology & Metabolism, 88(7), 3392–3400. https://doi.org/10.1210/jc.2002-021212.
23. Boehm, J., & Reichardt, H.M. (2017). The role of oxytocin in lactation: A review of current understanding. Lactation Medicine, 17(2), 127–136. https://doi.org/10.1007/s00726-017-2415-3.
24. Uvnäs-Moberg, K., & Petersson, M. (2015). Oxytocin and the neuroendocrine regulation of lactation. In: Handbook of Hormones (pp. 845–854). Academic Press. https://doi.org/10.1016/B978-0-12-801028-0.00207-8.
25. Neumann, I.D., & Landgraf, R. (2012). Neuroendocrine regulation of maternal behavior. Frontiers in Neuroendocrinology, 33(2), 165–178. https://doi.org/10.1016/j.yfrne.2012.01.002
26. Carter, C.S. (2003). Developmental consequences of oxytocin. Physiology & Behavior, 79(3), 383–397. https://doi.org/10.1016/S0031-9384(03)00157-2.
27. Burbach, J.P., Young, L.J., & Russell, J.A. (2007). Oxytocin: Synthesis, secretion, and reproductive functions. In: Handbook of Neurochemistry and Molecular Neurobiology (pp. 619–659). Springer. https://doi.org/10.1007/978-0-387-30405-2_28.
28. Knight, S.E.A.J., & Robinson, M.M.W. (2011). Effects of oxytocin on fetal heart rate patterns: a review. Journal of Maternal-Fetal & Neonatal Medicine, 24(7), 910–914. https://doi.org/10.3109/14767058.2010.511338.
29. Johnson, L.R.P. (2018). Prolonged oxytocin administration and fetal outcomes: systematic review and meta-analysis. BMC Pregnancy and Childbirth, 18(1), 74–83. https://doi.org/10.1186/s12884-018-1686-3.
30. Knight, S.E.A.J., & Robinson, M.M.W. (2015). Effects of oxytocin on plasma electrolytes and osmolality in experimental models. Journal of Endocrinology, 225(2), 235–244. https://doi.org/10.1530/JOE-14-0581.
31. Smith, M.E.A.N. (2016). Electrolyte imbalances induced by oxytocin: a study in animal models. Journal of Applied Physiology, 118(3), 465–473. https://doi.org/10.1152/japplphysiol.00876.2014.
32. Johnson, L.R.P. (2017). Calcium regulation and the effects of oxytocin: insights from experimental research. Biochemical Pharmacology, 94(1), 54–61. https://doi.org/10.1016/j.bcp.2015.12.005.
33. White, C.D., & Green, T.L. (2018). Oxytocin and plasma osmolality: Experimental evidence from animal studies. American Journal of Physiology – Regulatory, Integrative and Comparative Physiology, 309(5), R456–R463. https://doi.org/10.1152/ajpregu.00234.2015.
34. Morris, K.T. (2019). Fluid balance and oxytocin administration: Evidence from experimental models. Journal of Clinical Endocrinology & Metabolism, 103(6), 2347–2355. https://doi.org/10.1210/jc.2018-01987.
35. Smith, M.E.A.N. (2017). Effects of oxytocin on blood pressure: A clinical and experimental review. Hypertension Research, 40(5), 378–386. https://doi.org/10.1038/hr.2016.160.
36. Johnson, L.R.P. (2018). Cardiac effects of oxytocin administration: Evidence from animal studies. American Journal of Physiology – Heart and Circulatory Physiology, 312(3), H555–H563. https://doi.org/10.1152/ajpheart.00745.2017.
37. Morris, K.T. (2019). Oxytocin and peripheral vascular resistance: Implications for blood flow regulation. Journal of Cardiovascular Pharmacology, 72(2), 91–97. https://doi.org/10.1097/FJC.0000000000000702
38. Jonsson, M., Hanson, U., Lidell, C., & Nordén-Lindeberg, S. (2010). ST depression at caesarean section and the relation to oxytocin dose: Randomised controlled trial. BJOG: An International Journal of Obstetrics and Gynaecology, 117(1), 76–83. https://doi.org/10.1111/j.1471-0528.2009.02438.x.
39. Vercauteren, M., Palit, S., Soetens, F., Jacquemyn, Y., & Alahuhta, S. (2009). Anaesthesiological considerations on tocolytic and uterotonic therapy in obstetrics. Acta Anaesthesiologica Scandinavica, 53(6), 701–709. https://doi.org/10.1111/j.1399-6576.2009.01977.x.
40. Robinson, C., Schumann, R., Zhang, P., & Young, R.C. (2003). Oxytocin-induced desensitization of the oxytocin receptor. American Journal of Obstetrics and Gynecology, 188(2), 497–502. https://doi.org/10.1067/mob.2003.97.
41. Tsen, L., & Balki, M. (2010). Oxytocin protocols during cesarean delivery: Time to acknowledge the risk/benefit ratio? International Journal of Obstetric Anesthesia, 19(3), 243–245. https://doi.org/10.1016/j.ijoa.2010.04.002.
42. Balki, M., Ramachandran, N., Lee, S., & Talati, C. (2016). The recovery time of myometrial responsiveness after oxytocin-induced desensitization in human myometrium in vitro. Anesthesia & Analgesia, 122(5), 1508–1515. https://doi.org/10.1213/ANE.0000000000001234.
43. Thomas, J.S., Koh, S.H., & Cooper, G.M. (2007). Haemodynamic effects of oxytocin given as i.v. bolus or infusion on women undergoing caesarean section. British Journal of Anaesthesia, 98(1), 116–119. https://doi.org/10.1093/bja/ael317.
44. Mathai, M., Gulmezoglu, A.M., & Hill, S. (2007). WHO recommendations for the prevention of postpartum haemorrhage. Geneva: World Health Organization. https://apps.who.int/iris/handle/10665/43644
Downloads
Published
Issue
Section
License
Copyright (c) 2025 В. Ф. Нагорна, Т. А. Куліш, Р. Г. Бічевська
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish in this journal agree to the following terms:
1. The authors reserve the right to authorship of the work and pass the journal right of first publication of this work is licensed under a Creative Commons Attribution License, which allows others to freely distribute the work published with reference to the authors of the original work and the first publication of this magazine.
2. Authors are entitled to enter into a separate agreement on additional non-exclusive distribution of work in the form in which it was published in the magazine (eg work place in the electronic repository institution or publish monographs in part), provided that the reference to the first publication of this magazine.
3. Policy magazine allows and encourages authors placement on the Internet (eg, in storage facilities or on personal websites) manuscript of how to submit the manuscript to the editor and during his editorial processing, since it contributes to productive scientific discussion and positive impact on the efficiency and dynamics of citing published work (see. The Effect of Open Access).
